Evidence map›Paper›PMID 22990619›Full record

Trial reportJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2012

Dextromethorphan attenuated inflammation and combined opioid use in humans undergoing methadone maintenance treatment.

Shiou-Lan Chen, Sheng-Yu Lee, Pao-Luh Tao, Yun-Hsuan Chang, Shih-Heng Chen, Chun-Hsien Chu, Po See Chen, I Hui Lee, Tzung Lieh Yeh, Yen Kuang Yang and 2 more

Registry-linked trialAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05861544 (Pomegranate Juice Consumption by Patients Under Medication for Addiction Treatment as a Regulator of Craving and Blood Redox Status), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05861544 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Pomegranate Juice Consumption by Patients Under Medication for Addiction Treatment as a Regulator of Craving and Blood Redox Status: The Study Protocol of a Randomized Control Trial (the NUTRIDOPE Study)

TypeinterventionalSponsorOrganization Against Drugs (ΟΚΑΝΑ)Ran2023 to 2024Enrolled58ConditionsPsychiatryArmsPomegranate juice
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Neutrophil-lymphocyte and Platelet-lymphocyte Ratios among Adolescents with Substance Use Disorder: A Preliminary Study.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2021
    Article
  10. Article
  11. Article
  12. Increased Neutrophil-lymphocyte and Platelet-lymphocyte Ratios in Male Heroin Addicts: A Prospective Controlled Study.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Shiou-Lan ChenInstitute of Behavioral Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Sheng-Yu Lee
Pao-Luh Tao
Yun-Hsuan Chang
Shih-Heng Chen
Chun-Hsien Chu
Po See Chen
I Hui Lee
Tzung Lieh Yeh
Yen Kuang Yang
Jau-Shyong Hong
Ru-Band Lu
National Cheng Kung University · TWNational Health Research Institutes · TWNational Institutes of Health · US

Funding

Roles Of Brain Neuroimmune System In NeurodegenerationZIAES090082 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI HONG, JAU-SHYONG SHYONG · 2009 to 2018
$22.0M
6 · The paper itself

Abstract

Recent studies show that proinflammatory cytokines might be related to the development of opioid dependence (physiological, psychological, or both). In a double-blind, randomly stratified clinical trial investigating whether add-on dextromethorphan (60-120 mg/day) attenuated inflammation and the combined use of opioids in heroin-dependent patients undergoing methadone maintenance treatment, we evaluated whether inflammation is related to the progression of opioid dependence. All participants (107 heroin-dependent patients and 84 nondependent healthy controls) were recruited from National Cheng Kung University Hospital. Their plasma cytokine levels were measured to evaluate the effect of add-on dextromethorphan. Plasma TNF-α and IL-8 levels were significantly higher in long-term heroin-dependent patients than in healthy controls (p < 0.001). Chronic heroin-use-induced TNF-α and IL-8 levels were significantly (p < 0.05) attenuated in patients treated for 12 weeks with add-on dextromethorphan. Moreover, both tolerance to methadone and the combined use of opioids were significantly (p < 0.05) attenuated in patients taking dextromethorphan. We conclude that dextromethorphan might be a feasible adjuvant therapeutic for attenuating inflammation and inhibiting methadone tolerance and combined opioid use in heroin-dependent patients.

Indexed as

Analgesics, OpioidMethadoneAdultAmphetamineAmphetamine-Related DisordersCentral Nervous System StimulantsDextromethorphanDouble-Blind MethodFemaleHeroin DependenceHumansInflammationInterleukin-8MaleMiddle AgedMorphineAmphetamineAnalgesics, OpioidCentral Nervous System StimulantsDextromethorphanInterleukin-8MethadoneMorphineTumor Necrosis Factor-alpha

Identifiers

PMID22990619
OpenAlexW2022269638

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.